BENEVOLENTAI (BAI.AS) Stock Price, Quote, News and Overview
AMS:BAI - Euronext Amsterdam - LU2355630455 - Common Stock - Currency: EUR
BAI.AS Quote, Performance and Key Statistics
AMS:BAI (3/7/2025, 7:00:00 PM)
0.1095
+0 (+0.92%)
The current stock price of BAI.AS is 0.1095 EUR. In the past month the price decreased by -14.79%. In the past year, price decreased by -84.13%.
BAI.AS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1LLY.MI | ELI LILLY & CO | 67 | 760.43B | ||
| LLY.DE | ELI LILLY & CO | 66.98 | 760.15B | ||
| ZEG.DE | ASTRAZENECA PLC | 21.82 | 446.45B | ||
| JNJ.DE | JOHNSON & JOHNSON | 16.81 | 372.31B | ||
| 1JNJ.MI | JOHNSON & JOHNSON | 16.61 | 367.98B | ||
| NOV.DE | NOVO NORDISK A/S-B | 26.21 | 355.97B | ||
| SNW.DE | SANOFI | 14.32 | 275.64B | ||
| SAN.PA | SANOFI | 14.27 | 274.84B | ||
| 1SAN.MI | SANOFI | 14.19 | 273.18B | ||
| 6MK.DE | MERCK & CO. INC. | 12.64 | 224.82B | ||
| 1MRKX.MI | MERCK & CO. INC. | 12.47 | 221.79B | ||
| PFE.DE | PFIZER INC | 8.69 | 140.81B |
Related stock screener links
About BAI.AS
Company Profile
BenevolentAI SA is a holding company that engages in the research and development and sale of AI-enabled drugs. The firm designs its technology to enable scientists to better understand the development of disease mechanisms, discover drug targets and make decisions. The company serves patients by leveraging its proprietary and validated Benevolent Platform that integrates AI and science to uncover new biology, predict novel targets and develop drugs for complex diseases. The Benevolent Platform integrates technology, processes, and humans for faster research and development success. Its pipeline includes BEN-8744, BEN-28010, BEN-34712, Parkinson's disease, and Fibrosis. BEN-8744 is developed for the treatment of an ulcerative colitis. The firm provides scientists with a view of disease biology by integrating across all the domains and diverse data types, including omics, molecules, experimental data, literature, pathology, and biological systems.
Company Info
BENEVOLENTAI
4-8 Maple Street
London GB
Employees: 180
Company Website: https://www.benevolent.com/
Investor Relations: http://www.benevolent.com/investors
Phone: 442037819360
BENEVOLENTAI / BAI.AS FAQ
What is the stock price of BENEVOLENTAI today?
The current stock price of BAI.AS is 0.1095 EUR. The price increased by 0.92% in the last trading session.
What is the ticker symbol for BENEVOLENTAI stock?
The exchange symbol of BENEVOLENTAI is BAI and it is listed on the Euronext Amsterdam exchange.
On which exchange is BAI.AS stock listed?
BAI.AS stock is listed on the Euronext Amsterdam exchange.
What is the price forecast or stock price prediction for BENEVOLENTAI stock?
5 analysts have analysed BAI.AS and the average price target is 2.75 EUR. This implies a price increase of 2415.07% is expected in the next year compared to the current price of 0.1095. Check the BENEVOLENTAI stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BENEVOLENTAI worth?
BENEVOLENTAI (BAI.AS) has a market capitalization of 15.66M EUR. This makes BAI.AS a Nano Cap stock.
How many employees does BENEVOLENTAI have?
BENEVOLENTAI (BAI.AS) currently has 180 employees.
Is BENEVOLENTAI (BAI.AS) expected to grow?
The Revenue of BENEVOLENTAI (BAI.AS) is expected to decline by -31.89% in the next year. Check the estimates tab for more information on the BAI.AS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BENEVOLENTAI (BAI.AS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BAI.AS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BAI.AS, evaluating the profitability, health, valuation and growth aspects
- BENEVOLENTAI (BAI.AS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BENEVOLENTAI (BAI.AS) Sales and EPS estimates to see what analysts future expectations are.
- BENEVOLENTAI (BAI.AS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BENEVOLENTAI (BAI.AS) Insider and Institutional Ownership to learn about the owners and their transactions.
- BENEVOLENTAI (BAI.AS) Stock Chart to make your own analysis
- BENEVOLENTAI (BAI.AS) Latest news and press-releases to stay up to date.
Does BENEVOLENTAI (BAI.AS) stock pay dividends?
BAI.AS does not pay a dividend.
When does BENEVOLENTAI (BAI.AS) report earnings?
BENEVOLENTAI (BAI.AS) will report earnings on 2025-03-13, after the market close.
What is the Price/Earnings (PE) ratio of BENEVOLENTAI (BAI.AS)?
BENEVOLENTAI (BAI.AS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.51).
BAI.AS Technical Analysis
BAI.AS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BAI.AS. The financial health of BAI.AS is average, but there are quite some concerns on its profitability.
BAI.AS Financial Highlights
Over the last trailing twelve months BAI.AS reported a non-GAAP Earnings per Share(EPS) of -0.51. The EPS increased by 33.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -54.61% | ||
| ROE | -73.07% | ||
| Debt/Equity | 0.05 |
BAI.AS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to BAI.AS. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of 8.46% and a revenue growth -31.89% for BAI.AS